Fei Mao | Materials Science and | Best Researcher Award

ProfDr. Fei Mao | Materials Science and Engineering | Best Researcher Award

Researcher at Jiangsu University Affiliated People’s Hospital, China

Prof. Fei Mao is a highly accomplished biomedical researcher specializing in mesenchymal stem cells, exosomes, and their therapeutic applications in inflammatory bowel disease (IBD) and colorectal cancer. With over two decades of academic experience and a strong publication record spanning high-impact journals, his research demonstrates significant depth and innovation. His work has advanced understanding of molecular mechanisms such as miRNA regulation, pyroptosis, and gut microbiota interactions, highlighting its translational relevance. Prof. Mao’s international exposure, including a postdoctoral fellowship at MD Anderson Cancer Center, adds further value to his global scientific perspective. While expanding research breadth, increasing sole authorship in top-tier journals, and detailing grant and citation metrics could strengthen his profile, his consistent focus and leadership in this niche field make him a strong candidate for the Best Researcher Award. His contributions have had a meaningful impact on regenerative medicine and the potential treatment of chronic gastrointestinal diseases.

Professional Profile

Education🎓

Prof. Fei Mao has a strong academic foundation rooted in medical and pharmaceutical sciences. He began his academic journey with a Bachelor’s degree in Medical Examination from the School of Medicine at Jiangsu University (1997–2002), followed by a Master’s degree in Pharmacognostics at the College of Food Science and Technology, also at Jiangsu University (2002–2005). He further advanced his expertise by earning a Ph.D. in Medicine from the School of Medicine, Jiangsu University (2004–2010), where he developed a strong focus on biomedical research. To broaden his research experience and global exposure, he completed a postdoctoral fellowship at the prestigious MD Anderson Cancer Center, University of Texas, USA (2012–2014), one of the world’s leading cancer research institutions. Since 2018, Prof. Mao has been serving as a Professor at the School of Medicine, Jiangsu University, where he continues to lead research initiatives and mentor the next generation of medical scientists.

Professional Experience📝

Prof. Fei Mao has built a distinguished professional career in biomedical research and academia. He began his postdoctoral training at the renowned MD Anderson Cancer Center, University of Texas, USA (2012–2014), where he deepened his expertise in cancer biology and regenerative medicine. Upon returning to China, he joined the School of Medicine at Jiangsu University, where he has served as a Professor since 2018. In this role, he has led numerous research projects focused on mesenchymal stem cells, exosomes, and their therapeutic applications in inflammatory bowel disease and colorectal cancer. His professional work is characterized by a strong translational focus, aiming to bridge the gap between laboratory findings and clinical treatments. Prof. Mao has published extensively in peer-reviewed journals, contributed to scientific reviews and book chapters, and collaborated with international researchers. His leadership in academic research and dedication to innovation have earned him recognition as a key figure in his field.

Research Interest🔎

Prof. Fei Mao’s research interests lie at the intersection of regenerative medicine, immunology, and gastrointestinal diseases. His primary focus is on the therapeutic potential of mesenchymal stem cells (MSCs) and exosomes in treating inflammatory bowel disease (IBD) and related colorectal cancer. He is particularly interested in understanding the molecular and cellular mechanisms through which MSCs and their exosomes modulate immune responses, regulate macrophage function, and influence pathways such as ubiquitination, pyroptosis, ferroptosis, and the gut microbiota-metabolome axis. By exploring the roles of microRNAs, long non-coding RNAs, and key signaling pathways like JAK/STAT and ERK, his research aims to uncover novel therapeutic targets and improve treatment strategies for chronic inflammatory conditions. Prof. Mao’s work bridges basic science and clinical application, contributing to the development of next-generation cell-based therapies. His dedication to this niche field positions him as a leading researcher in stem cell therapy and gastrointestinal disease intervention.

Award and Honor🏆

While specific awards and honors are not explicitly listed in the provided profile, Prof. Fei Mao’s academic achievements and research contributions strongly suggest a career marked by professional recognition. His appointment as a Professor at Jiangsu University since 2018 reflects institutional trust and recognition of his expertise. His postdoctoral fellowship at the prestigious MD Anderson Cancer Center, University of Texas, indicates international recognition of his potential and scientific capability. Additionally, his extensive publication record in reputable international journals highlights his research impact and standing within the scientific community. His collaborative work with global researchers and leadership in innovative studies on stem cell therapies for inflammatory bowel disease further underline his influence in the field. It is likely that Prof. Mao has received internal university commendations, research grants, and possibly national or regional awards in China, which would be consistent with the level of academic productivity and impact demonstrated throughout his career.

Research Skill🔬

Prof. Fei Mao possesses a comprehensive and advanced set of research skills in the fields of regenerative medicine, molecular biology, and immunology. His expertise lies in the isolation and therapeutic application of mesenchymal stem cells (MSCs) and exosomes, particularly in the treatment of inflammatory bowel disease (IBD) and colorectal cancer. He is highly skilled in designing and conducting in vivo and in vitro experiments, utilizing mouse models to study disease mechanisms and therapeutic outcomes. Prof. Mao has extensive experience in molecular techniques such as gene expression analysis, microRNA profiling, western blotting, immunohistochemistry, and pathway analysis involving signaling molecules like NF-κB, JAK/STAT, and ERK. He also has strong capabilities in gut microbiota and metabolomic research, integrating omics technologies to understand host-microbe interactions. His ability to translate complex molecular findings into therapeutic insights demonstrates not only technical proficiency but also a deep understanding of biomedical research with clinical relevance.

Conclusion💡

Prof. Fei Mao is a highly suitable candidate for a Best Researcher Award, particularly in the biomedical and translational medicine fields. His focused research on mesenchymal stem cells and inflammatory diseases has made valuable contributions to both basic science and potential clinical applications.

While some diversification and additional metrics (citations, grants) would further validate his standing, his sustained publication output, innovative methodologies, and international experience strongly support the merit of this nomination.

Publications Top Noted✍

  1. Title: Advancing therapeutic strategies for graft-versus-host disease by targeting gut microbiome dynamics in allogeneic hematopoietic stem cell transplantation: current evidence and future directions
    Authors: Not provided
    Year: Not provided
    Citations: 0

  2. Title: Human umbilical cord mesenchymal stem cell-derived exosomes repair IBD by activating the SIRT1-FXR pathway in macrophages
    Authors: Not provided
    Year: 2025
    Citations: 0

  3. Title: The role of COX-2 and its use as a therapeutic target in IBD and related colorectal cancer
    Authors: Not provided
    Year: Not provided
    Citations: 0

  1. Title: Mesenchymal stem cell in immunomodulation of dendritic cells: Implications for inflammatory bowel disease therapy
    Authors: Not provided
    Year: Not provided
    Citations: 0

  2. Title: HucMSC-Ex alleviates inflammatory bowel disease by regulating O-GlcNAcylation modification of RACK1 in intestinal epithelial cells
    Authors: Not provided
    Year: 2025
    Citations: 0

  1. Title: Flos lonicerae polysaccharide alleviates inflammatory bowel disease by improving intestinal microbiota and inhibiting oxidative stress and the NF-κB pathway
    Authors: Not provided
    Year: 2025
    Citations: 0

  1. Title: Emerging role of small RNAs in inflammatory bowel disease and associated colorectal cancer (Review)
    Authors: Not provided
    Year: Not provided
    Citations: 2

  1. Title: The role of suppressor of cytokine signaling 3 in inflammatory bowel disease and its associated colorectal cancer
    Authors: Not provided
    Year: Not provided
    Citations: 0

  1. Title: Intestinal mucus barrier: A potential therapeutic target for IBD
    Authors: Not provided
    Year: Not provided
    Citations: 5

  2. Title: Mechanism of cell death and its application in the repair of inflammatory bowel disease by mesenchymal stem cells
    Authors: Not provided
    Year: Not provided
    Citations: Not provided

Jianwu Zhou | Materials Science and Engineering | Best Researcher Award

Assoc. Prof. Dr. Jianwu Zhou | Materials Science and Engineering | Best Researcher Award

Associate. Professor at Nanjing University of Aeronautics and Astronautics, China

Dr. Jianwu Zhou is a dedicated scholar and emerging expert in the field of composite material mechanics, specializing in the study of impact dynamics and interlaminar strengthening of composite laminates. Throughout his academic and professional journey, Dr. Zhou has continuously demonstrated an exceptional aptitude for tackling complex problems in material engineering, especially in the realm of low-velocity and high-velocity impact behaviors. His research endeavors focus on understanding how composite structures behave under various impact conditions and how damage influences their residual performance. Known for his analytical mindset and practical contributions to the field, Dr. Zhou actively bridges the gap between theoretical modeling and applied engineering solutions, particularly in developing techniques for real-time health monitoring of composite materials. His collaborative spirit, innovative methodology, and consistent academic output have made him a respected figure among his peers in aeronautical and mechanical engineering communities.

profile

scopus

Education

Dr. Jianwu Zhou embarked on his academic pursuit of engineering excellence with a firm commitment to the study of composite materials. He earned his Doctor of Philosophy (Ph.D.) degree with a specialization in impact dynamics and the mechanical performance of composite structures. His doctoral research laid the groundwork for his future investigations into the behavior of composite materials under both high and low-velocity impacts, as well as the development of strategies to enhance their damage tolerance through advanced interlaminar reinforcement techniques, such as Z-pin technology. Dr. Zhou’s educational background combines strong theoretical knowledge with hands-on experimental research, which has shaped his comprehensive understanding of composite material science.

Experience

Dr. Zhou’s professional journey exemplifies both academic dedication and real-world application. He began his postdoctoral research at the School of Aeronautics, Northwestern Polytechnical University in April 2023, where he worked until April 2025. During this period, he expanded his research on impact damage, health monitoring systems, and the residual strength of advanced composite structures. Following his postdoctoral training, Dr. Zhou assumed the role of Associate Professor at the College of Energy and Power Engineering, Nanjing University of Aeronautics and Astronautics in April 2025. His academic appointments reflect a rapid trajectory of career advancement, highlighting his capability to produce impactful research and mentor future engineers and scholars in the field of composite materials.

Research Interest

Dr. Jianwu Zhou’s research interests lie at the heart of modern composite material engineering, with a primary focus on understanding and improving the impact resistance and post-impact performance of composite laminates. His work emphasizes the study of mechanical behaviors under both low-velocity and high-velocity impacts, the integration of Z-pin reinforcement to bolster interlaminar strength, and the development of experimental and modeling techniques to predict failure mechanisms. Furthermore, Dr. Zhou is deeply invested in the application of on-line health monitoring systems for composite materials, aiming to ensure the safety and longevity of aerospace structures. His investigations not only contribute to fundamental material science but also hold critical importance for practical engineering applications in aviation and defense industries.

Award

Dr. Jianwu Zhou’s exemplary research achievements and scholarly contributions have positioned him as a strong candidate for professional recognition and academic awards. His work on the dynamics of composite structures and interlaminar reinforcement using Z-pin technologies has attracted considerable attention within the academic community. His publications in top-tier journals, experimental research innovations, and collaborative efforts with leading aerospace universities underscore his dedication to advancing the field of material science. With his demonstrated expertise, innovation, and academic integrity, Dr. Zhou is a fitting nominee for this prestigious award.

Publication

Dr. Jianwu Zhou has contributed significantly to his field through the following peer-reviewed publications:

Zhou J., Zhang C., Jia L., “A new integrated modeling method for predicting low-velocity impact behavior and residual tensile failure of Z-pinned T-joints,” Composites Science and Technology, 2024, 245, 110316 — cited by multiple follow-up studies on composite joint analysis.

Zhou J., Zhao Z., Shi Y.*, Wang X., Chen X., Shan C., “Hail impact responses and residual tensile properties of CFRP T-joints,” Chinese Journal of Aeronautics, 2023, 36, 430–443 — referenced by aerospace impact assessment papers.

Zhou J., Shi Y.*, Zuo Y., Shan C., Gu Z., “Experimental investigation into influences of Z-pin and deltoid on structural properties and damage tolerance of CFRP T-joints,” Composites Part B: Engineering, 2022, 237, 109875 — cited in structural health monitoring research.

Zhou J., Liao B., Shi Y.*, Ning L., Zuo Y., Jia L., “Experimental investigation of the double impact position effect on the mechanical behavior of low-velocity impact in CFRP laminates,” Composites Part B: Engineering, 2020, 193, 108020 — widely cited for multi-impact damage behavior.

Zhou J., Liao B., Shi Y.*, Zuo Y., Tuo H., Jia L., “Low-velocity impact behavior and residual tensile strength of CFRP laminates,” Composites Part B: Engineering, 2019, 161, 300–313 — frequently referenced for baseline CFRP performance testing.

Conclusion

Dr. Jianwu Zhou’s dedication, innovative thinking, and impressive publication record make him a highly deserving candidate for the Best Researcher Award. His work not only deepens scientific understanding but also offers practical solutions to industry challenges, embodying the true spirit of impactful and forward-looking research. His continued contributions promise to shape the future of material science and engineering, making him an outstanding role model in the academic and research community.

Hernández Gutiérrez – Materials Science and Engineering – Best Researcher Award

Hernández Gutiérrez - Materials Science and Engineering - Best Researcher Award

CIATEJ-CONAHCYT - Mexico

AUTHOR PROFILE

ORCID

AWARDS AND RECOGNITIONS 🏆

Throughout his illustrious career, Hernández Gutiérrez has received numerous awards for his groundbreaking research. Notably, he was honored with the Premio Estatal de Ciencia, Tecnología e Innovación in 2021 for his project on serum analysis in early-stage breast cancer. His work has consistently earned accolades, including the prestigious Premio Aida Weiss from UNAM in 2015, underscoring his commitment to advancing cancer diagnostics and treatment.

INNOVATIONS IN CANCER DIAGNOSTICS AND THERAPEUTICS 🧬

Hernández Gutiérrez has been instrumental in developing innovative diagnostic tools and therapeutic strategies for cancer. His research has led to the creation of novel methods for detecting and treating cancer, such as the use of recombinant proteins and peptide vaccines. These innovations have potential applications in early cancer detection and targeted therapy, significantly improving patient outcomes.

PATENTED BIOMEDICAL TECHNOLOGIES 🔬

Hernández Gutiérrez is a prolific inventor, holding several patents related to cancer diagnostics and therapeutics. His patented technologies include biomarkers and recombinant proteins for the early detection of breast and lung cancer. These inventions demonstrate his expertise in translating research into practical applications that have the potential to revolutionize cancer care.

CONTRIBUTIONS TO SARS-COV-2 RESEARCH 🦠

In response to the global COVID-19 pandemic, Hernández Gutiérrez contributed to research on neutralizing antibody responses to the Delta variant of SARS-CoV-2. His work, published in high-impact journals, provided crucial insights into the efficacy of vaccines, particularly in the Mexican population. This research highlights his versatility and ability to address urgent public health challenges.

EDUCATION AND MENTORSHIP 🎓

A dedicated educator, Hernández Gutiérrez has mentored numerous students and researchers, guiding them in their scientific pursuits. His commitment to education is evident in his involvement in various academic conferences and his role in developing young talent in the field of biomedical research.

PUBLIC ENGAGEMENT AND SCIENTIFIC OUTREACH 🌍

Beyond the laboratory, Hernández Gutiérrez is passionate about public engagement and scientific outreach. He has delivered lectures and participated in science communication initiatives, such as his contributions to the Planetario y Centro Interactivo de Jalisco. His efforts to make science accessible to the broader public demonstrate his dedication to fostering a scientifically informed society.

NOTABLE PUBLICATION

Synergistic Strategies in Prostate Cancer Therapy: Electrochemotherapy and Electromagnetic Hyperthermia
Authors: Sayma Vizcarra-Ramos, Andrea Molina-Pineda, Abel Gutiérrez-Ortega, Sara E. Herrera-Rodríguez, Adriana Aguilar-Lemarroy, Luis F. Jave-Suárez, Zaira López, Mario E. Cano, Rodolfo Hernández-Gutiérrez
Journal: Pharmaceutics
Year: 2024-08-23

The Fluorescent Cell Line SW620-GFP Is a Valuable Model to Monitor Magnetic Hyperthermia
Authors: Saray Rosales, Rodolfo Hernández-Gutiérrez, Alma Oaxaca, Zaira López, Norberto Casillas, Peter Knauth, Luis H. Quintero, José A. Paz, Francisco Cholico, Celso Velásquez
Journal: Bioengineering
Year: 2024-06-21

The Value of CXCL1, CXCL2, CXCL3, and CXCL8 as Potential Prognosis Markers in Cervical Cancer: Evidence of E6/E7 from HPV16 and 18 in Chemokines Regulation
Authors: Leonardo Fernandez-Avila, Aribert Maryosly Castro-Amaya, Andrea Molina-Pineda, Rodolfo Hernández-Gutiérrez, Luis Felipe Jave-Suarez, Adriana Aguilar-Lemarroy
Journal: Biomedicines
Year: 2023-09-28

Embedded Living HER2+ Cells in a 3D Gelatin–Alginate Hydrogel as an In Vitro Model for Immunotherapy Delivery for Breast Cancer
Authors: G. Tonantzin De Dios-Figueroa, Janette del Rocío Aguilera-Márquez, Lorena García-Uriostegui, Rodolfo Hernández-Gutiérrez, Tanya A. Camacho-Villegas, Pavel H. Lugo-Fabres
Journal: Polymers
Year: 2023-09-11

Tetrahydroxyquinone: A Suitable Coating for Ferrofluids Used in Magnetic Hyperthermia
Authors: Ana G. González, Norberto Casillas, Zaira López, Oscar Cervantes, Peter Knauth, Rodolfo Hernández-Gutiérrez, Antonio Topete-Camacho, Saray Rosales, Luis H. Quintero, José A. Paz
Journal: Coatings
Year: 2022-08-05